¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vitamin preparation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitamin D-resistant rickets
    ºñŸ¹ÎDÀúÇ×±¸·çº´
  • vitamin E
    ºñŸ¹ÎE
  • vitamin K
    ºñŸ¹ÎK
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • solid preparation
    °íÇüÁ¦Á¦
  • thyroid preparation
    ¹æÆÐ»ùÁ¦Á¦, °©»ó»ùÁ¦Á¦
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nutrient preparation
    ¿µ¾çÇ¥º», ¿µ¾ç¹°(ç½å×Úª).
  • organ preparation
    Àå±âÁ¦Á¦, Àå±âÁغñ(Àå±âÁغñ).
  • organ preparation
    ±â°üÁ¦Á¦, ±â°üÁغñ(ÐïίñÞÝá).
  • patient preparation
    ȯÀÚÁغñ
  • permanent preparation
    ¿µ
  • permanent preparation
    ¿µ±¸Ç¥º»(¡­øöÜâ).
  • pharmaceutical preparation
    Á¦Á¦(ð²ð¥).
  • preparation
    Á¶Á÷Ç¥º»
  • semisolid preparation
    ¹Ý°íÇüÁ¦Á¦(Úâͳû¡ð² ð¥).
  • sinoatrial preparation
    µ¿¹æ½Ã·á(÷ÓÛ®ãËè÷).
  • skin preparation
    ÇǺÎÁغñ(¡­Áغñ).
  • smear preparation
    µµ¸»Ç¥º»(ÓóØÆøöÜâ)
  • solid preparation
    °íÇüÁ¦Á¦(ͳû¡ð²ð¥).
  • specimen preparation
    °ËüÁغñ
  • tzanck preparation
    âũǥº»
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitamin A1 acid
    ºñŸ¹Î A1 »ê(ß«)
  • vitamin A1 alcohol
    ºñŸ¹Î A1 ¾ËÄÚȦ
  • vitamin A1 aldehyde
    ºñŸ¹Î A1 ¾Ëµ¥ÇÏÀ̵å
  • vitamin B
    ºñŸ¹Î B
  • vitamin B1
    ºñŸ¹Î B1
  • vitamin B2
    ºñŸ¹Î B2
  • vitamin B3
    ºñŸ¹Î B3
  • vitamin B5
    ºñŸ¹Î B5
  • vitamin B6
    ºñŸ¹Î B6
  • vitamin B12
    ºñŸ¹Î B12
  • vitamin B complex
    ºñŸ¹Î B º¹ÇÕü (ÜÜùêô÷)
  • Vitamin B group
    ºñŸ¹Î B ±º(ÏØ)
  • vitamin C
    ºñŸ¹Î C
  • vitamin D
    ºñŸ¹Î D
  • vitamin D1
    ºñŸ¹Î D1
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DBP diastolic blood pressure; dibutylphthalate; distobuccopulpal; Dohle body panmyelopathy; vitamin D-bi...
HVDRR hypocalcemic vitamin D-resistant rickets
PIVKA protein induced by vitamin K absence or antagonism
UBBC unsaturated vitamin B12 binding capacity
VAD venous access device; ventricular assist device; vinblastine and dexamethasone; vitamin A deficiency...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VDR 1,25-dihydroxy-vitamin D3 receptor
VDR D/vitamin D receptor
hVDR Human vitamin D receptor
PIVKA-II Protein induced by vitamin K absence or antagonist II
UBBC Unsaturated vitamin B12 binding capacity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • unstained preparation
    ºñ¿°»ö Ç¥º»
  • antirachitic vitamin
    Ç×±¸·çº´¼º ºñŸ¹Î
  • serum vitamin B12
    Ç÷û ºñŸ¹Î B12
  • vitamin A
    ºñŸ¹Î A
  • vitamin B 21
    ºñŸ¹ÎB 21
  • vitamin B complex
    ºñŸ¹ÎB º¹ÇÕü
  • vitamin B12
    ºñŸ¹Î B12
    ½Ã¾Æ³ëÄڹ߶ó¹Î. Ç׺óÇ÷ ÀÎÀڷμ­ Àû»ö °áÁ¤. 4°³ÀÇ ÇÇ·Ñ ÇÙÀÇ 3°³ÀÇ Åº¼Ò ¿øÀÚ¿Í 6°³ÀÇ °ø¿ª ÀÌÁß °áÇÕÀ» Áö´Ñ ȯ»ó ±¸Á¶¸¦ ÀÌ·ç¸ç ÄÚ¹ßÆ®¸¦ Áö´Ñ´Ù. ½Ã¾È±â°¡ ÄÚ¹ßÆ®¿¡ ¹èÀ§°áÇÕÇØ ÀÖ´Ù. ºñŸ¹Î B12´Â ¼ö¿ë¼ºÀÌ¸ç ¾ËÄڿÿ¡ ¿ëÇØÇÏÁö¸¸ ¾Æ¼¼Åæ, ¿¡Å׸£¿¡´Â ³ìÁö ¾Ê´Â´Ù. »ê¿¡ ¾ÈÁ¤, ¾ËÄ®¸®¿¡´Â ºÒ¾ÈÁ¤ÇÏ´Ù. Co¿øÀÚ¿¡ °áÇÕÇÑ ½Ã¾È±â ´ë½Å¿¡ OH±â¶ó¸é ÇÏÀ̵å·Î¿Á½Ã Äڹ߶ó¹Î, CH3±â¶ó¸é ¸ÞÆ¿ Äڹ߶ó¹ÎÀ̶ó°í ÇÑ´Ù. ½Ã¾Æ³ë Äڹ߶ó¹Î ¼ö¿ë¾×Àº 278nm, 361nm, 548nm¿¡¼­ ÃÖ´ëÇÑ Èí¼öµÈ´Ù. ÀÌ ºñŸ¹ÎÀº Á¶Ç÷ ±â±¸¿¡ Áß¿äÇϸç, RNA¿¡¼­ DNAÀÇ Çü¼º ¹ÝÀÀ¿¡ °ü¿©ÇÑ´Ù°í »ý°¢µÈ´Ù. ½Ä»çÁßÀÇ ºñŸ¹Î B12´Â ¼ÒÀå Á¾¸»ºÎ¿¡¼­ Ä®½·, À§º®¿¡¼­ »ý»êµÇ´Â ³»ÀÎÀÚ ¹«ÄڴܹéÀÇ Á¸Àç ¾Æ·¡ Èí¼öµÈ´Ù. Ç÷û ¹Ý°¨±â´Â ¾à 1ÁÖÀÏÀÌ´Ù.
  • vitamin B12-intrinsic factor
    ºñŸ¹Î B12-³»Àμº ÀÎÀÚ
  • vitamin B2 deficiency
    ºñŸ¹Î B2 °áÇÌÁõ
  • vitamin C
    ºñŸ¹Î C
    ¾Æ½ºÄݺó»ê. Ç×±«Ç÷Áõ ÀÛ¿ëÀ» ÇÑ´Ù. ¿­¿¡ ¾àÇÏ°í °­·ÂÇÑ È¯¿ø ÀÛ¿ëÀÌ ÀÖ¾î, ¿©·¯ È¿¼ÒÀÇ ÀÛ¿ë ¹ßÇö¿¡ ÀÖ¾î Àû´çÇÑ »êȭȯ¿ø »óÅÂÀÇ À¯Áö¿¡ µµ¿òÀÌ µÇ¸ç, ¼ö¼Ò¿î¹Ýü·Î¼­ ÀÛ¿ëÇϰí ÀÖ´Ù. »êÈ­´Â ºû, ¾ËÄ®¸®, ö, ±¸¸®¿¡ ÀÇÇÏ¿© ÃËÁøµÈ´Ù. ½ºÅ×·ÎÀÌµå »ýÇÕ¼º ¶§ÀÇ ¼ö»êÈ­¿¡µµ ¾Æ½ºÄÚ¸£ºó »êÀÌ °ü¿©ÇÑ´Ù.
  • vitamin compound
    ºñŸ¹Î º¹ÇÕÁ¦
    ºñŸ¹ÎÀ» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¿µ¾çÁ¦·Î¼­ ºñŸ¹Î °áÇÌÁõÀÇ Ä¡·á¿Í ¿¹¹æ¿¡ »ç¿ëµÇ´Â ÀǾàǰ. ÇöÀç ºñŸ¹Î B2¸¦ Á¦¿ÜÇÑ ´ëºÎºÐÀÇ ºñŸ¹ÎµéÀº ÇÕ¼ºÇÒ ¼ö ÀÖ°í È­Çлê¾÷¿¡ ÀÇÇØ ´Ù·®À¸·Î Á¦Á¶°¡ °¡´ÉÇϹǷΠ´ëºÎºÐÀÇ ºñŸ¹ÎÁ¦´Â ÇÕ¼ºÇ°À¸·Î ¸¸µé¾îÁø´Ù. ´ÜÀÏ Á¦Á¦ Áß¿¡ ÇÑ Á¾·ùÀÇ ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç ´ÜÀÏ ºñŸ¹ÎÁ¦, Áö¿ë¼º ÈæÀº ¼ö¿ë¼º ºñŸ¹Î ¸î Á¾·ù¸¸À» º¹ÇÕ½ÃÄÑ ¸¸µç º¹ÇÕ ºñŸ¹ÎÁ¦, °ÅÀÇ ¸ðµç ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç Á¾ÇÕ ºñŸ¹ÎÁ¦°¡ ÀÖ¾î ¿ëµµ¿¡ µû¶ó »ç¿ëµÈ´Ù. ºñŸ¹ÎÁ¦´Â Áúº´, ¾Ë·¹¸£±â, ½Ä»çÀÇ Á¦ÇÑ µî ¾î¶² ÀÌÀ¯¿¡¼­ ÀûÀýÇÑ ½Ä»ç¸¦ ÇÏÁö ¸øÇÏ´Â »ç¶÷¿¡°Ô´Â ¸Å¿ì À¯¿ëÇϳª Á¤±Ô½Ä»ç¸¦ ÇÏ´Â °Ç°­ÇÑ »ç¶÷ÀÌ ºñŸ¹ÎÀ» ´õ º¸Ãæ¼·ÃëÇϱâ À§ÇÏ¿© »ç¿ëÇÏ´Â °ÍÀº ³¶ºñÀ̰ųª ÇØ°¡ µÇ´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î »ï°¡¾ß ÇÑ´Ù. 5°¡Áö ±âÃʽÄǰ±º¿¡ ±âº»À» µÐ ±ÕÇü½Ä»ç´Â ¸öÀÌ ÇÊ¿ä·Î ÇÏ´Â ¸ðµç ºñŸ¹ÎÀ» °ø±ÞÇϱ⿡ ÃæºÐÇϸç, Çʿ䷮ ÀÌ»óÀÇ ºñŸ¹ÎÀÌ °Ç°­¿¡ ÇØ·Ó±â ¶§¹®ÀÌ´Ù. Á¤±Ô½Ä»ç¸¦ ÅëÇÑ ºñŸ¹ÎÀÇ ¼·Ãë´Â °áÄÚ °úÀ× µ¶¼º¼öÁرîÁö °¡Áö ¾ÊÁö¸¸, ³óÃàµÈ ºñŸ¹ÎÁ¦¸¦ °è¼Ó ¸ÔÀ¸¸é °úÀ× µ¶¼º ¼öÁرîÁö À̸£°Ô µÈ´Ù. ½Ä»ç¸¦ ÅëÇÏ¿© °Ç°­À¯Áö¿Í Áúº´¿¹¹æ¿¡ ÇÊ¿äÇÑ ¸ðµç ºñŸ¹ÎÀ» ¼·ÃëÇØ¾ß ÇÑ´Ù.
  • vitamin D
    ºñŸ¹ÎD
    ºñŸ¹ÎÀÇ ÇѰ¡Áö. Ç÷¾× ¼ÓÀÇ Ä®½·À» Á¶ÀýÇÏ¸ç °áÇÌµÇ¸é ±¸·çº´ÀÌ µÊ. °£À¯, ´Þ°¿ ³ë¸¥ÀÚ µûÀ§¿¡ µé¾î ÀÖÀ½.
  • vitamin D deficiency
    ºñŸ¹Î D °áÇÌ, ºñŸ¹Î D °áÇÌÁõ
    ±¸·çº´-°ñ¿¬È­ÁõÀ¸·Î µî»À³ª °¡½¿»À µûÀ§°¡ ±Á´Â º´. °ö»çº´.
  • vitamin D dependency
    ºñŸ¹Î D ÀÇÁ¸¼º
  • vitamin D milk
    ºñŸ¹ÎD ¿ìÀ¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
b-complex vitamin <biochemistry> A group of vitamins that includes: B1(thiamin), B2 riboflavin), B3 (niacin), B6(pyridoxine), B12 (cobalamin) and folate.
(24 Mar 1998)
vitamin <biochemistry> An essential low molecular weight organic compound required in trace amounts for normal growth and metabolic processes. They usually serve as components of coenzyme systems.
For humans Vitamin A, the B series, C, D1 and D2, E and K are required. Deficiencies of one or more vitamins in the nutrient supply result in deficiency diseases.
(11 Nov 1997)
vitamin A <biochemistry> Deficiency of this vitamin interferes with the production of rhodopsin in the eye resulting in night blindness and xerophthalmia.
(27 Sep 1997)
vitamin A1 Vitamin A1alcohol; 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene;a half-carotene bearing the b (or beta-ionone) form of the cyclic end group and a CH2OH at the C-15 position (numbering as in carotenoids) or 9'-position (numbering as a nonyl side chain on a cyclohexene ring); an intermediate in the vision cycle, it also plays a role in growth and differentiation.
See: dehydroretinol.
Synonym: vitamin A1 alcohol, vitamin A1.
Retinol dehydrogenase, an oxidoreductase catalyzing interconversion of retinal and NADH to retinol and NAD+.
(05 Mar 2000)
vitamin A1 acid <biochemistry> The aldehyde (retinal) has long been known to be involved in photoreception, but retinoic acid has other roles.
There are cytoplasmic retinoic acid binding proteins and retinoic acid response elements that regulate gene transcription. Retinoic acid is thought to be a morphogen in chick limb bud development and in early development of the chick that probably accounts for its potent teratogenic action.
Synonym: vitamin A.
(03 Jul 1999)
vitamin A1 alcohol Vitamin A1alcohol; 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene;a half-carotene bearing the b (or beta-ionone) form of the cyclic end group and a CH2OH at the C-15 position (numbering as in carotenoids) or 9'-position (numbering as a nonyl side chain on a cyclohexene ring); an intermediate in the vision cycle, it also plays a role in growth and differentiation.
See: dehydroretinol.
Synonym: vitamin A1 alcohol, vitamin A1.
Retinol dehydrogenase, an oxidoreductase catalyzing interconversion of retinal and NADH to retinol and NAD+.
(05 Mar 2000)
vitamin A2 3-Dehydroretinol;retinol with an additional double bond in the 3-4 position of the cyclohexane ring.
Synonym: vitamin A2.
(05 Mar 2000)
vitamin A2 aldehyde 3-Dehydroretinaldehyde;dehydroretinol with -CHO instead of -CH2OH at the terminal carbon of the side chain.
Synonym: retinene-2, vitamin A2 aldehyde.
(05 Mar 2000)
vitamin A aldehyde <chemical> A carotenoid constituent of visual pigments. It is the oxidised form of retinol which functions as the active component of the visual cycle.
It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in "dark" reactions to return to the native trans-configuration.
Chemical name: Retinal
(03 Jul 1999)
vitamin a deficiency A nutritional condition produced by a deficiency of vitamin a in the diet, characterised by night blindness and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (xerophthalmia). Vitamin a deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin a-rich foods. In the united states it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption.
(12 Dec 1998)
vitamin A unit The specific biologic activity of 0.3 ug of vitamin A (alcohol form).
See: Sherman-Munsell unit.
(05 Mar 2000)
vitamin B A group of water-soluble substances originally considered as one vitamin.
(05 Mar 2000)
vitamin B1 <biochemistry> A member of the water-soluble B vitamin group, necessary for energy production and carbohydrate metabolism. Deficiency is known as beriberi.
(27 Sep 1997)
vitamin B12 <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism.
(27 Sep 1997)
vitamin b 12 <chemical> A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin b 12 from the soil and so are a poor source of the substance as compared with animal tissues.
Pharmacological action: haematinics.
Chemical name: Vitamin B12
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á